Biopreservation Market Size 2026-2030
The biopreservation market size is valued to increase by USD 4.24 billion, at a CAGR of 17.5% from 2025 to 2030. Advancements in regenerative medicine and cell and gene therapies will drive the biopreservation market.
Major Market Trends & Insights
- North America dominated the market and accounted for a 38.5% growth during the forecast period.
- By End-user - Life sciences and healthcare facilities segment was valued at in 2024
- By Application - Biobanks segment accounted for the largest market revenue share in 2024
Market Size & Forecast
- Market Opportunities: USD 5.97 billion
- Market Future Opportunities: USD 4.24 billion
- CAGR from 2025 to 2030 : 17.5%
Market Summary
- The biopreservation market is integral to modern biomedical advancement, providing the foundational technologies for preserving the viability of cells, tissues, and other biological materials. Growth is largely fueled by the expansion of cell and gene therapies, which depend on flawless cryopreservation protocols from collection to patient administration.
- A key trend involves the integration of automation and sustainable practices, as research facilities seek to enhance efficiency and reduce their environmental footprint. For instance, a mid-sized biotechnology firm implementing automated cryogenic storage and repository management software can improve sample integrity assurance while adhering to strict GLP compliance requirements.
- This transition allows for better management of biospecimen lifecycle management and supports scalable biobanking infrastructure. However, the significant capital investment required for ultra-low temperature (ULT) freezers and liquid nitrogen (LN2) systems remains a substantial barrier, particularly for smaller research institutions and startups.
- Balancing technological adoption with budget constraints is a critical operational challenge, influencing purchasing decisions and the pace of innovation across the industry as it moves toward more advanced vitrification techniques and automated thawing systems.
What will be the Size of the Biopreservation Market during the forecast period?
Get Key Insights on Market Forecast (PDF) Request Free Sample
How is the Biopreservation Market Segmented?
The biopreservation industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2026-2030, as well as historical data from 2020-2024 for the following segments.
- End-user
- Life sciences and healthcare
- Research laboratories
- Others
- Application
- Bio banking
- Regenerative medicine
- Drug discovery
- Product
- Equipment
- Media
- LIMS
- Geography
- North America
- US
- Canada
- Mexico
- Asia
- Europe
- Germany
- UK
- France
- Rest of World (ROW)
- North America
By End-user Insights
The life sciences and healthcare segment is estimated to witness significant growth during the forecast period.
The life sciences and healthcare segment is foundational to the biopreservation market, driven by complex cell and gene therapy (CGT) applications and broad regenerative medicine support.
This sector's reliance on robust biobanking infrastructure for drug discovery sample management and clinical trial sample management necessitates advanced solutions for cellular material preservation. Effective biospecimen lifecycle management is critical, requiring stringent quality control in biobanking and validated cryopreservation equipment.
To meet these demands, organizations are adopting GMP-grade cell banking protocols and sophisticated biorepository data management systems for long-term biological sample storage.
The use of specialized serum-free cryopreservation media is also expanding, with automated systems now enabling up to a 90% reduction in manual sample handling errors.
The Life sciences and healthcare segment was valued at in 2024 and showed a gradual increase during the forecast period.
Regional Analysis
North America is estimated to contribute 38.5% to the growth of the global market during the forecast period.Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
See How Biopreservation Market Demand is Rising in North America Request Free Sample
The geographic landscape of the biopreservation market is led by North America, which captures over 38% of the incremental growth, driven by its advanced research infrastructure and high investment in biotechnology.
The region's leadership is reinforced by stringent regulatory standards, including FDA 21 CFR Part 11 compliance, which necessitates sophisticated repository management software and biological material storage solutions.
Meanwhile, Asia is the fastest-growing region, with a projected growth rate exceeding 18%, fueled by expanding healthcare access and government-led research initiatives. The adoption of automated thawing systems and advanced tissue engineering preservation techniques is accelerating in this region.
Effective use of dry vapor shipping containers for ambient temperature shipping solutions is crucial for maintaining sample integrity across global supply chains, with optimized logistics reducing sample degradation risk during transit by up to 25%.
Market Dynamics
Our researchers analyzed the data with 2025 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
- The biopreservation market is evolving rapidly, shaped by both opportunities and economic realities. The significant cost-benefit analysis of automated biobanking systems is a central concern for many institutions, as the initial investment can be substantial. However, the long-term operational savings and improved sample integrity often justify the expense.
- This is particularly true in the context of advanced medical applications where the impact of freeze-thaw cycles on cell viability can determine therapeutic success. As a result, there is intense focus on developing serum-free media for cryopreservation to enhance post-thaw recovery.
- The push for GMP-compliant cryopreservation for cell therapies is setting new industry benchmarks, demanding stringent validation of cryogenic shipping for clinical trials to ensure that materials arrive in optimal condition. Concurrently, regulatory guidelines for long-term tissue storage are becoming more defined, pushing organizations to adopt best practices.
- Innovations are also prominent, with research dedicated to optimizing cooling rates for organ cryopreservation and ensuring the long-term stability of vitrified oocytes. Advanced facilities now report that automated sample retrieval is over five times faster than manual processes, significantly accelerating research timelines.
What are the key market drivers leading to the rise in the adoption of Biopreservation Industry?
- Significant advancements in regenerative medicine and cell and gene therapies are a key driver of market growth, demanding sophisticated preservation for viable biological materials.
- The biopreservation market is propelled by rapid advancements in regenerative medicine, where organ preservation technology and advanced therapy medicinal products (ATMPs) depend on flawless preservation.
- The success of these therapies hinges on maintaining high cell viability assessment scores, which are ensured through precise controlled-rate freezers and the use of effective cryoprotective agents (CPAs).
- The entire value chain relies on robust cold chain logistics management to transport materials for gamete and embryo cryopreservation and cord blood banking services.
- As clinical pipelines expand, the need for aseptic processing and adherence to good manufacturing practice (GMP) standards becomes paramount.
- The market is seeing a surge in demand for specialized cryogenic logistics services and controlled-rate freezing protocols, with investments in enabling technologies for microbial culture preservation securing over eight-figure funding rounds to support clinical progression.
What are the market trends shaping the Biopreservation Industry?
- A significant upcoming market trend is the increasing focus on sustainable and eco-friendly biopreservation solutions. This shift is driven by the need to reduce operational costs and the environmental impact of energy-intensive storage equipment.
- A primary trend in the biopreservation market is the move toward sustainable and automated solutions. Organizations are increasingly adopting energy-efficient freezer technology to reduce operational costs and environmental impact, with some systems cutting energy use by over 40%.
- This shift aligns with the growing demand for automated cell cryopreservation systems and biological sample tracking software, which together enhance sample integrity assurance and minimize human error. Innovations in biopreservation media, including non-DMSO cryoprotectants, are crucial for improving post-thaw outcomes by mitigating ice crystal formation.
- The development of advanced vitrification techniques and lyophilization processes further supports the preservation of delicate biologicals like exosomes. Moreover, advancements in cryogenic vial and tube design and adherence to liquid nitrogen safety protocols are becoming standard for ensuring both sample security and personnel safety.
What challenges does the Biopreservation Industry face during its growth?
- The high cost of acquiring and maintaining advanced biopreservation technologies and infrastructure presents a key challenge to industry growth and wider market adoption.
- A significant challenge confronting the biopreservation market is the high capital and operational cost of essential infrastructure. Establishing cryogenic sample storage solutions, including ultra-low temperature (ULT) freezers and liquid nitrogen (LN2) systems, requires substantial investment, creating barriers for smaller institutions. Adherence to stringent cryopreservation protocols and the validation of storage conditions add to the complexity and expense.
- The total cost is further elevated by the need for high-quality sterile consumables for cryo-storage and passive temperature-controlled packaging. Optimizing heat transfer dynamics and cryopreservation reagent formulation is critical for achieving high sample recovery rates and post-thaw viability metrics.
- These financial pressures are compounded by the necessity for GLP compliance requirements, forcing organizations to balance innovation with budget constraints and driving the need for risk mitigation in biostorage strategies.
Exclusive Technavio Analysis on Customer Landscape
The biopreservation market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the biopreservation market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape of Biopreservation Industry
Competitive Landscape
Companies are implementing various strategies, such as strategic alliances, biopreservation market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.
ARCTIKO AS - Delivering integrated sample management solutions, from automated cold storage to lifecycle software, that ensure the integrity of critical biological assets for research and therapeutic development.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
- ARCTIKO AS
- Avantor Inc.
- Azenta US Inc.
- BioLife Solutions Inc.
- Bio Techne Corp.
- Chart Industries Inc.
- Cryoport Systems, LLC
- Helmer Scientific Inc.
- IC Biomedical LLC
- Merck KGaA
- NIPPON Genetics EUROPE GmbH
- OPS Diagnostics LLC
- PHC Holdings Corp.
- QIAGEN N.V.
- Shanghai Genext Medical Tech.
- So-Low Environmental Co
- STEMCELL Technologies Inc.
- Thermo Fisher Scientific Inc.
- ThermoGenesis Holdings Inc.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Recent Development and News in Biopreservation market
- In May, 2025, Azenta Inc. announced a strategic partnership with Form Bio to create an integrated sequencing and AI-powered data analysis solution designed to accelerate AAV gene therapy development.
- In March, 2025, Johnson and Johnson announced an investment of over USD 55 billion in its US operations over four years, including new manufacturing facilities requiring biopreservation solutions.
- In February, 2025, Thermo Fisher Scientific launched the Krios 5 Cryo-TEM, a next-generation platform utilizing AI-powered automation for atomic-resolution imaging to advance structural biology techniques.
- In January, 2025, Azenta Inc. was selected by the UK Biocentre to deploy its BioArc Ultra high-density, automated storage system, expanding the facility's sample capacity by approximately 16 million.
Dive into Technavio’s robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Biopreservation Market insights. See full methodology.
| Market Scope | |
|---|---|
| Page number | 284 |
| Base year | 2025 |
| Historic period | 2020-2024 |
| Forecast period | 2026-2030 |
| Growth momentum & CAGR | Accelerate at a CAGR of 17.5% |
| Market growth 2026-2030 | USD 4235.5 million |
| Market structure | Fragmented |
| YoY growth 2025-2026(%) | 16.4% |
| Key countries | US, Canada, Mexico, China, Japan, India, South Korea, Indonesia, Thailand, Singapore, Germany, UK, France, Italy, Spain, The Netherlands, Russia, Australia, UAE, Brazil, South Africa, Saudi Arabia and Turkey |
| Competitive landscape | Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Research Analyst Overview
- The biopreservation market is a critical enabler of advancements in the life sciences, particularly for cell and gene therapy (CGT) applications and regenerative medicine support. The industry's core function revolves around ensuring sample integrity assurance through sophisticated cryogenic storage, vitrification techniques, and lyophilization processes.
- At the boardroom level, a key strategic decision involves investing in sustainable biopreservation media and ultra-low temperature (ULT) freezers that align with corporate environmental goals while reducing operational expenditures. For instance, next-generation liquid nitrogen (LN2) systems can lower energy consumption by over 30% compared to older models.
- Effective cold chain logistics management is essential for maintaining cell viability assessment metrics and supporting complex drug discovery sample management. The market is also driven by the need for adherence to good manufacturing practice (GMP) standards, GLP compliance requirements, and FDA 21 CFR Part 11 compliance, making controlled-rate freezers and advanced repository management software indispensable for modern biobanking infrastructure.
What are the Key Data Covered in this Biopreservation Market Research and Growth Report?
-
What is the expected growth of the Biopreservation Market between 2026 and 2030?
-
USD 4.24 billion, at a CAGR of 17.5%
-
-
What segmentation does the market report cover?
-
The report is segmented by End-user (Life sciences and healthcare facilities, Research laboratories, and Others), Application (Biobanks, Regenerative medicine, and Drug discovery), Product (Equipment, Media, and LIMS) and Geography (North America, Asia, Europe, Rest of World (ROW))
-
-
Which regions are analyzed in the report?
-
North America, Asia, Europe and Rest of World (ROW)
-
-
What are the key growth drivers and market challenges?
-
Advancements in regenerative medicine and cell and gene therapies, Cost of advanced biopreservation technologies and infrastructure
-
-
Who are the major players in the Biopreservation Market?
-
ARCTIKO AS, Avantor Inc., Azenta US Inc., BioLife Solutions Inc., Bio Techne Corp., Chart Industries Inc., Cryoport Systems, LLC, Helmer Scientific Inc., IC Biomedical LLC, Merck KGaA, NIPPON Genetics EUROPE GmbH, OPS Diagnostics LLC, PHC Holdings Corp., QIAGEN N.V., Shanghai Genext Medical Tech., So-Low Environmental Co, STEMCELL Technologies Inc., Thermo Fisher Scientific Inc. and ThermoGenesis Holdings Inc.
-
Market Research Insights
- The biopreservation market is characterized by a dynamic shift toward integrated, automated cell cryopreservation systems that enhance efficiency and data management. This evolution in organ preservation technology addresses the complex demands of clinical trial sample management and long-term biological sample storage for advanced therapy medicinal products (ATMPs).
- Leading solutions now offer significant operational advantages, with advanced energy-efficient freezer technology reducing power consumption by over 40% compared to legacy equipment. Furthermore, the adoption of biological sample tracking software and automation in GMP-grade cell banking improves sample retrieval speeds by more than 200%, minimizing risks associated with manual handling.
- These advancements in cryogenic sample storage solutions and cord blood banking services are becoming critical differentiators for organizations focused on scalability and compliance.
We can help! Our analysts can customize this biopreservation market research report to meet your requirements.